The design concept of this combination aims to integrate Vimentin’s high detection ability for invasive tumors and POU4F2’s high sensitivity for early tumors, with the goal of achieving more comprehensive and robust detection across different stages/grades of BC. The gene discussed is VIM; the disease is breast cancer.